Heart failure as a complication of COVID-19 infection: systematic review and meta-analysis.


Journal

Acta cardiologica
ISSN: 1784-973X
Titre abrégé: Acta Cardiol
Pays: England
ID NLM: 0370570

Informations de publication

Date de publication:
Apr 2022
Historique:
pubmed: 4 6 2021
medline: 15 4 2022
entrez: 3 6 2021
Statut: ppublish

Résumé

The prevalence and prognostic implications of heart failure (HF), as a complication of COVID-19 infection remains unclear. We performed a systematic review and metanalysis aimed to evaluate the pooled incidence of acute HF as a cardiac complication of COVID-19 disease and to estimate the related mortality risk in these patients. Data were obtained searching MEDLINE, Scopus and Web of Science for all investigations published any time to 26 December 2020. If statistical heterogeneity was 50%, the results were derived from the fixed-effects model otherwise the random-effects model. Overall, 1064 patients [mean age 66 years, 618 males] were included in the final analysis reviewing six investigations. The cumulative in-hospital rate of COVID-19 patients complicated by acute HF ranged between 6.9 and 63.4% among the studies reviewed. A random effect model revealed a pooled incidence of COVID-19 patients complicated by acute HF in 20.2% of cases (95% CI: 11.1-33.9%, Acute HF represents a frequent complication of COVID-19 infection associated with a higher risk of mortality in the short-term period.

Sections du résumé

BACKGROUND/OBJECTIVES OBJECTIVE
The prevalence and prognostic implications of heart failure (HF), as a complication of COVID-19 infection remains unclear. We performed a systematic review and metanalysis aimed to evaluate the pooled incidence of acute HF as a cardiac complication of COVID-19 disease and to estimate the related mortality risk in these patients.
METHODS METHODS
Data were obtained searching MEDLINE, Scopus and Web of Science for all investigations published any time to 26 December 2020. If statistical heterogeneity was 50%, the results were derived from the fixed-effects model otherwise the random-effects model.
RESULTS RESULTS
Overall, 1064 patients [mean age 66 years, 618 males] were included in the final analysis reviewing six investigations. The cumulative in-hospital rate of COVID-19 patients complicated by acute HF ranged between 6.9 and 63.4% among the studies reviewed. A random effect model revealed a pooled incidence of COVID-19 patients complicated by acute HF in 20.2% of cases (95% CI: 11.1-33.9%,
CONCLUSIONS CONCLUSIONS
Acute HF represents a frequent complication of COVID-19 infection associated with a higher risk of mortality in the short-term period.

Identifiants

pubmed: 34080948
doi: 10.1080/00015385.2021.1890925
doi:

Types de publication

Journal Article Meta-Analysis Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

107-113

Auteurs

Marco Zuin (M)

Department of Translational Medicine, University of Ferrara, Ferrara, Italy.

Gianluca Rigatelli (G)

Department of Cardiology, Santa Maria della Misericordia Hospital, Rovigo, Italy.

Claudio Bilato (C)

Division of Cardiology, West Vicenza General Hospitals, Arzignano, Italy.

Giovanni Zuliani (G)

Department of Translational Medicine, University of Ferrara, Ferrara, Italy.

Loris Roncon (L)

Department of Cardiology, Santa Maria della Misericordia Hospital, Rovigo, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH